^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    mesothelin-targeted CAR-T immunotherapy

    i
    Associations
    News

    Trials

    Company:
    Shanghai Unicar
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. (NCT03267173)
    Phase 1
    First Affiliated Hospital of Harbin Medical Uni...
    Unknown status
    Last update posted :
    08/30/2017
    Initiation :
    06/15/2017
    Primary completion :
    06/01/2019
    Completion :
    06/01/2019
    HER-2 • PSCA
    |
    mesothelin-targeted CAR-T immunotherapy